|
Market Closed -
Other stock markets
|
After market 03:33:00 pm | |||
| 67.95 EUR | +0.15% |
|
67.8 | -0.22% |
| May. 06 | MORPHOSYS : UBS reiterates its Neutral rating | ZD |
| Apr. 30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
MorphoSys AG reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was EUR 27.54 million compared to EUR 24.35 million a year ago. Net loss was EUR 314.96 million compared to EUR 44.43 million a year ago.
Basic loss per share from continuing operations was EUR 8.27 compared to EUR 0.94 a year ago. Diluted loss per share from continuing operations was EUR 8.27 compared to EUR 0.94 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +99.85% | 2.76B | |
| +29.66% | 49.18B | |
| +0.94% | 42.11B | |
| +50.47% | 40.37B | |
| -5.26% | 28.85B | |
| +13.58% | 26.09B | |
| -22.77% | 18.71B | |
| +8.35% | 13.26B | |
| +32.12% | 12.32B | |
| -0.89% | 11.99B |
MORPHOSYS AG 
